Live from the NIH registry
Studies recruiting near Norfolk right now
Top 25 of 400 recruiting studies, sorted by proximity — each links to its official registry page
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
Cancer Specialists of Tidewater Limited — Chesapeake, Virginia (5.3 mi)
· Sponsor: SWOG Cancer Research Network
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Children's Hospital of The King's Daughters — Norfolk, Virginia (3.6 mi)
· Sponsor: National Cancer Institute (NCI)
A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphosphatemia
Hyperphosphatemia, Chronic Kidney Disease Requiring Chronic Dialysis
Phase 2
Interventional 168 participants sought
DaVita Clinical Research Norfolk — Norfolk, Virginia (3.6 mi)
· Sponsor: R1 Therapeutics
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma
Phase 2
Interventional 40 participants sought
Ohio State University-Telemedicine — Norfolk, Virginia (3.6 mi)
· Sponsor: Sameek Roychowdhury
Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma
Urothelial Cancer, Bladder Cancer
Phase 2, Phase 3
Interventional 630 participants sought
Research Site — Norfolk, Virginia (3.6 mi)
· Sponsor: Daiichi Sankyo
A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)
Neovascular Age-related Macular Degeneration
Phase 4
Interventional 188 participants sought
Wagner Kapoor Institute — Norfolk, Virginia (3.6 mi)
· Sponsor: Genentech, Inc.
A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy
Locally Advanced Head and Neck Squamous Cell Carcinoma
Phase 3
Interventional 1,145 participants sought
Research Site — Norfolk, Virginia (3.6 mi)
· Sponsor: AstraZeneca
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
Epithelial Ovarian Cancer, Fallopian Tube Cancer
Phase 2
Interventional 140 participants sought
Virginia Oncology Associates- Norfolk (Brock) /ID# 275227 — Norfolk, Virginia (3.6 mi)
· Sponsor: AbbVie
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
Percutaneous Coronary Intervention, Peripheral Endovascular Intervention
Phase 4
Interventional 6,000 participants sought
TPMG Clinical Research — Newport News, Virginia (11.1 mi)
· Sponsor: Duke University
Oxytocin/Foley vs. Oxytocin for Induction in Patients With PPROM
Preterm PROM (Pregnancy)
Phase 4
Interventional 80 participants sought
Sentara Norfolk General Hospital — Norfolk, Virginia (3.6 mi)
· Sponsor: Eastern Virginia Medical School
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Carcinoma, Transitional Cell, Urinary Bladder Neoplasms
Phase 3
Interventional 450 participants sought
USO - Virginia Oncology Associates — Norfolk, Virginia (3.6 mi)
· Sponsor: Eli Lilly and Company
Safety and Efficacy Study of Intracystic TARA-002 for the Treatment of Lymphatic Malformations in Participants 6 Months to Less Than 18 Years of Age
Lymphatic Malformation
Phase 2
Interventional 38 participants sought
Children's Hospital of the King's Daughters — Norfolk, Virginia (3.6 mi)
· Sponsor: Protara Therapeutics
A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)
Heart Failure
Phase 3
Interventional 1,500 participants sought
CON-10009, Norfolk, VA — Norfolk, Virginia (3.6 mi)
· Sponsor: Colorado Prevention Center
PReSeRVE-HD: Observational Study of the Merit HeRO® Graft and Super HeRO® in Patients on Hemodialysis
End Stage Renal Disease, Hemodialysis Access Failure
N/A
Observational 100 participants sought
Sentara Norfolk General Hospital — Norfolk, Virginia (3.6 mi)
· Sponsor: Merit Medical Systems, Inc.
Cast Art for Kids With Extremity Fractures
Fractures, Bone
N/A
Interventional 96 participants sought
Naval Medical Center Portsmouth — Portsmouth, Virginia (4.6 mi)
· Sponsor: United States Naval Medical Center, Portsmouth
A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain
Obesity, Knee Osteoarthritis (OA)
Phase 3
Interventional 400 participants sought
Health Res of Hampton Roads — Newport News, Virginia (11.1 mi)
· Sponsor: Novo Nordisk A/S
Study of Tucatinib and Doxil in Participants With Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Metastatic Breast Cancer
Breast Cancer
Phase 2
Interventional 36 participants sought
Virginia Oncology Associates — Norfolk, Virginia (3.6 mi)
· Sponsor: SCRI Development Innovations, LLC
Effect of Fiber Supplementation on the Need for Medication With Gestational Diabetes
Gestational Diabetes Mellitus (GDM)
N/A
Interventional 110 participants sought
Macon & Joan Brock Virginia Health Sciences at ODU — Norfolk, Virginia (3.6 mi)
· Sponsor: Eastern Virginia Medical School
The Vanguard Study: Testing a New Way to Screen for Cancer
Bladder Carcinoma, Breast Carcinoma
N/A
Interventional 24,000 participants sought
Sentara Norfolk General Hospital — Norfolk, Virginia (3.6 mi)
· Sponsor: National Cancer Institute (NCI)
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Diabetes Mellitus, Type 2, Hypertension
Phase 3
Interventional 11,800 participants sought
York Clinical Research — Norfolk, Virginia (3.6 mi)
· Sponsor: Boehringer Ingelheim
Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy
Urothelial Cancer
Phase 2, Phase 3
Interventional 470 participants sought
Local Institution - 0188 — Norfolk, Virginia (3.6 mi)
· Sponsor: Bristol-Myers Squibb
Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate Cancer
Prostate Cancer
Phase 3
Interventional 192 participants sought
Hampton University Proton Therapy Institute — Hampton, Virginia (10.5 mi)
· Sponsor: Proton Collaborative Group
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Triple-Negative Breast Cancer
Phase 3
Interventional 1,530 participants sought
Virginia Oncology Associates (VOA) ( Site 8008) — Norfolk, Virginia (3.6 mi)
· Sponsor: Merck Sharp & Dohme LLC
PK, PD, Safety, and Efficacy Study of Gefurulimab in Pediatric Patients With AChR+ Generalized Myasthenia Gravis
Generalized Myasthenia Gravis, gMG
Phase 3
Interventional 12 participants sought
Research Site — Norfolk, Virginia (3.6 mi)
· Sponsor: Alexion Pharmaceuticals, Inc.
An Open-label Study of JSB462 (Luxdegalutamide) in Combination With Abiraterone in Adult Male Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)
Metastatic Hormone-sensitive Prostate Cancer
Phase 2
Interventional 150 participants sought
Virginia Oncology Associates — Norfolk, Virginia (3.6 mi)
· Sponsor: Novartis Pharmaceuticals